Pioneering red light-activated anti-tumor prodrug reduces side effects -- ScienceDaily
Pioneering red light-activated anti-tumor prodrug reduces side effects — ScienceDaily
Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient’s blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as “collateral damage,” leading to undesired side effects. Aiming to overcome this problem, Dr Zhu Guangyu, Associate Professor of Department of Chemistry,…
View On WordPress














